On June 6, 2019, Aimed Alliance joined 55 other organizations in signing onto a letter from the MAPRx Coalition to the House Ways and Means and the House Energy and Commerce Committees. The letter responded to draft legislation jointly introduced by the Committees that would impact Medicare Part D beneficiaries. The Coalition offers several recommendations to improve the Medicare Part D prescription drug program, including the following:
• Establishing an out-of-pocket (OOP) cap, which would limit the amount Medicare beneficiaries pay for prescription drugs;
• Increasing clarity and transparency to improve beneficiaries’ ability to compare coverage levels, formularies, and OOP costs across plans;
• Improving the Part D Low-Income Subsidy (LIS) Program by eliminating the asset test and streamlining administration of the Extra Help Program; and
• Increasing oversight of challenges that patients experience when utilizing the Part D benefit, including narrow formularies, erosion of beneficiary protections, increased utilization management, use of preferred pharmacy networks, and problems with the exceptions and appeals processes.
Read the letter to learn more.
Last Updated on May 14, 2020 by Aimed Alliance
